Rheumatoid arthritis, γδ T cells and bisphosphonates-Reference-Cited by-同舟云学术

Rheumatoid arthritis, γδ T cells and bisphosphonates

Published:2017-10-26 Issue:9 Volume:77 Page:e57-e57
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Rossini Maurizio^ORCID,Adami Giovanni^ORCID,Viapiana Ombretta,Idolazzi Luca,Fassio Angelo,Giollo Alessandro^ORCID,Caimmi Cristian,Orsolini Giovanni,Gatti Davide

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference14 articles.

1. Chemotaxis of Vδ2 T cells to the joints contributes to the pathogenesis of rheumatoid arthritis

2. Distribution of Double-Negative (CD4 − CD8 − , DN) T Subsets in Blood and Synovial Fluid from Patients with Rheumatoid Arthritis

3. Selective expansion of t cells bearing the γ/δ receptor and expressing an unusual repertoire in the synovial membrane of patients with rheumatoid arthritis

4. IL-1 receptor antagonist-deficient mice develop autoimmune arthritis due to intrinsic activation of IL-17-producing CCR2+Vγ6+γδ T cells

5. Functionally distinct subsets of human γ/δ T cells

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prostaglandin E2 increases the production of IL‐17 and the expression of costimulatory molecules on γδ T cells in rheumatoid arthritis;Scandinavian Journal of Immunology;2020-02-28

2. Osteoporosis in Rheumatic Diseases;International Journal of Molecular Sciences;2019-11-22

3. Zoledronic acid plus methylprednisolone versus zoledronic acid or placebo in symptomatic knee osteoarthritis: a randomized controlled trial;Therapeutic Advances in Musculoskeletal Disease;2019-01

4. Update on novel pharmacological therapies for osteoarthritis;Therapeutic Advances in Musculoskeletal Disease;2019-01

5. New insights on the role, pathogenesis, and treatment of osteoporosis and bone erosions in rheumatoid arthritis;CLIN CASES MINER BON;2018